HeartBeam, Inc. (BEAT) vs Context Therapeutics Inc. (CNTX)

A side-by-side comparison of HeartBeam, Inc. and Context Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
HeartBeam, Inc. logo
BEAT
HeartBeam, Inc.
$33M
$0.59HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Context Therapeutics Inc. logo
CNTX
Context Therapeutics Inc.
$29M
$0.32HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — BEAT vs CNTX

growth of $100 · dividends reinvested · last 5y
BEAT -86.1% (-32.6%/yr)CNTX -93.6% (-42.2%/yr)BEAT compounded faster over this window
050100Start $10020222023202420252026$14$6
BEAT CNTX

BEAT vs CNTX: by the numbers

  • •BEAT is the larger company ($33M vs $29M market cap).

Metrics side by side

Valuation

MetricBEATCNTX
P/B ratio3.990.77

Profitability

MetricBEATCNTX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-248.21%-120.40%
ROIC-249.58%-126.84%

Go deeper

Full BEAT analysisFull CNTX analysisInteractive comparison tool

Dig into the metrics

HeartBeam ROEContext Therapeutics ROEHeartBeam operating marginContext Therapeutics operating marginHeartBeam revenue growthContext Therapeutics revenue growthHeartBeam free cash flowContext Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.